Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Australia
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 183204-72-0
2. Tipiracil Hcl
3. Tipiracil (hydrochloride)
4. Tipiracil Hydrochloride [usan]
5. Tas-1-462
6. 4h59klq0a4
7. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hydrochloride
8. Chembl65375
9. Ma-1 Hydrochloride
10. Tpi
11. Unii-4h59klq0a4
12. Tipiracil.hcl
13. 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4(1h,3h)-dione Hydrochloride
14. Tipiracilhydrochloride
15. Tipiracil Monohydrochloride
16. 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1h-pyrimidine-2,4-dione;hydrochloride
17. Schembl1682924
18. Chebi:90877
19. Ex-a882
20. Dtxsid001027748
21. Amy25415
22. Bcp06245
23. Ex-a1393
24. Hy-a0063
25. Tipiracil Hydrochloride (jan/usan)
26. Tipiracil Hydrochloride [mi]
27. Mfcd01571384
28. S3731
29. Tipiracil Hydrochloride [jan]
30. Akos027427002
31. Ccg-267234
32. Cs-1637
33. Tipiracil Hydrochloride [who-dd]
34. 2,4(1h,3h)-pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-, Hydrochloride (1:1)
35. Ac-30634
36. As-56082
37. Tipiracil Hydrochloride, >=98% (hplc)
38. Db-065426
39. Ft-0700247
40. Tipiracil Hydrochloride [orange Book]
41. A13098
42. D10467
43. Lonsurf Component Tipiracil Hydrochloride
44. A847265
45. S-95005 Component Tipiracil Hydrochloride
46. Tas-102 Component Tipiracil Hydrochloride
47. Tipiracil Hydrochloride Component Of Lonsurf
48. J-690251
49. Q27162848
50. 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil Hydrochloride
51. 5-chloro-6-(1-(2-iminopyrrolidinyl)-methyl)uracil Hydrochloride
52. 2,4(1h,3h)-pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl] Hydrochloride
53. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hcl
54. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dionehydrochloride
55. 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
56. 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4-(1h,3h)-pyrimidinedione Hydrochloride
57. 1-[(5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]pyrrolidin-2-iminium Chloride
58. 2,4(1h,3h)-pyrimidinedione, 5-chloro-6-((2-imino-1-pyrrolidinyl)methyl)-, Hydrochloride (1:1)
59. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hydrochloride;tipiracil Hcl
60. 5-chloro-6-(2-imino-pyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
Molecular Weight | 279.12 g/mol |
---|---|
Molecular Formula | C9H12Cl2N4O2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 278.0337310 g/mol |
Monoisotopic Mass | 278.0337310 g/mol |
Topological Polar Surface Area | 85.3 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 404 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Tipiracil Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tipiracil Hydrochloride manufacturer or Tipiracil Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tipiracil Hydrochloride manufacturer or Tipiracil Hydrochloride supplier.
PharmaCompass also assists you with knowing the Tipiracil Hydrochloride API Price utilized in the formulation of products. Tipiracil Hydrochloride API Price is not always fixed or binding as the Tipiracil Hydrochloride Price is obtained through a variety of data sources. The Tipiracil Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride, including repackagers and relabelers. The FDA regulates 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride supplier is an individual or a company that provides 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride active pharmaceutical ingredient (API) or 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride finished formulations upon request. The 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride suppliers may include 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride DMFs exist exist since differing nations have different regulations, such as 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride USDMF includes data on 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride Drug Master File in Korea (5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride. The MFDS reviews the 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride KDMF as part of the drug registration process and uses the information provided in the 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride suppliers with KDMF on PharmaCompass.
A 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride written confirmation (5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride WC) is an official document issued by a regulatory agency to a 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride manufacturer, verifying that the manufacturing facility of a 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride APIs or 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride suppliers with NDC on PharmaCompass.
5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride GMP manufacturer or 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride GMP API supplier for your needs.
A 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride's compliance with 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride specifications and serves as a tool for batch-level quality control.
5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride EP), 5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride USP).